Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7708612> ?p ?o }
Showing triples 1 to 72 of
72
with 100 triples per page.
- Q7708612 subject Q20870725.
- Q7708612 subject Q6184475.
- Q7708612 subject Q7145142.
- Q7708612 subject Q7215865.
- Q7708612 subject Q7930599.
- Q7708612 subject Q8367244.
- Q7708612 subject Q8569934.
- Q7708612 subject Q8672733.
- Q7708612 subject Q8788974.
- Q7708612 subject Q8844648.
- Q7708612 abstract "Tezampanel (INN, USAN) (code names LY-293,558, NGX-424) is a drug originally developed by Eli Lilly which acts as a competitive antagonist of the AMPA and kainate subtypes of the ionotropic glutamate receptor family, with selectivity for the GluR5 subtype of the kainate receptor. It has neuroprotective and anticonvulsant properties, the former of which may, at least in part, occur via blockade of calcium uptake into neurons.Tezampanel has a range of effects which may be useful for medicinal purposes, as well as its applications in scientific research. It suppresses both the withdrawal symptoms from morphine and other opioids, and the development of tolerance, as well as having antihyperalgesic and analgesic effects in its own right. It also has anxiolytic effects in animal studies and has been suggested as a candidate for the treatment of anxiety in humans.".
- Q7708612 atcPrefix "none".
- Q7708612 casNumber "150131-78-5".
- Q7708612 fdaUniiCode "GA36S2O9C2".
- Q7708612 iupacName "(3S,4aR,6R,8aR)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid".
- Q7708612 pubchem "127894".
- Q7708612 thumbnail Tezampanel.png?width=300.
- Q7708612 wikiPageWikiLink Q11190.
- Q7708612 wikiPageWikiLink Q12745592.
- Q7708612 wikiPageWikiLink Q154430.
- Q7708612 wikiPageWikiLink Q1633866.
- Q7708612 wikiPageWikiLink Q169872.
- Q7708612 wikiPageWikiLink Q17079236.
- Q7708612 wikiPageWikiLink Q173235.
- Q7708612 wikiPageWikiLink Q18026547.
- Q7708612 wikiPageWikiLink Q19596736.
- Q7708612 wikiPageWikiLink Q19597602.
- Q7708612 wikiPageWikiLink Q1981368.
- Q7708612 wikiPageWikiLink Q20870725.
- Q7708612 wikiPageWikiLink Q21098868.
- Q7708612 wikiPageWikiLink Q213907.
- Q7708612 wikiPageWikiLink Q2464757.
- Q7708612 wikiPageWikiLink Q295251.
- Q7708612 wikiPageWikiLink Q3454536.
- Q7708612 wikiPageWikiLink Q427523.
- Q7708612 wikiPageWikiLink Q43054.
- Q7708612 wikiPageWikiLink Q46857.
- Q7708612 wikiPageWikiLink Q4926095.
- Q7708612 wikiPageWikiLink Q498902.
- Q7708612 wikiPageWikiLink Q5156356.
- Q7708612 wikiPageWikiLink Q5348096.
- Q7708612 wikiPageWikiLink Q576618.
- Q7708612 wikiPageWikiLink Q6184475.
- Q7708612 wikiPageWikiLink Q62903.
- Q7708612 wikiPageWikiLink Q632240.
- Q7708612 wikiPageWikiLink Q640448.
- Q7708612 wikiPageWikiLink Q6460431.
- Q7708612 wikiPageWikiLink Q706.
- Q7708612 wikiPageWikiLink Q7145142.
- Q7708612 wikiPageWikiLink Q7215865.
- Q7708612 wikiPageWikiLink Q7930599.
- Q7708612 wikiPageWikiLink Q81225.
- Q7708612 wikiPageWikiLink Q824258.
- Q7708612 wikiPageWikiLink Q8367244.
- Q7708612 wikiPageWikiLink Q8386.
- Q7708612 wikiPageWikiLink Q8569934.
- Q7708612 wikiPageWikiLink Q8672733.
- Q7708612 wikiPageWikiLink Q8788974.
- Q7708612 wikiPageWikiLink Q8844648.
- Q7708612 atcPrefix "none".
- Q7708612 casNumber "150131".
- Q7708612 iupacName "-6".
- Q7708612 pubchem "127894".
- Q7708612 unii "GA36S2O9C2".
- Q7708612 type ChemicalSubstance.
- Q7708612 type Drug.
- Q7708612 type ChemicalObject.
- Q7708612 type Thing.
- Q7708612 type Q8386.
- Q7708612 comment "Tezampanel (INN, USAN) (code names LY-293,558, NGX-424) is a drug originally developed by Eli Lilly which acts as a competitive antagonist of the AMPA and kainate subtypes of the ionotropic glutamate receptor family, with selectivity for the GluR5 subtype of the kainate receptor.".
- Q7708612 label "Tezampanel".
- Q7708612 depiction Tezampanel.png.